UNSPSC 51401800: Tranquilizers and antimanic and antianxiety azepines

This classification denotes tranquilizers and antimanic and antianxiety drugs made from seven membered heterocyclic rings containing a NITROGEN atom.

UNSPSC 51401800 Tranquilizers and antimanic and antianxiety azepines is a Class code that in practice encompasses a broader pharmaceutical procurement activity than its name suggests — state and local governments are buying generic multi-source pharmaceuticals, over-the-counter products, and opioid-reversal agents (naloxone) through this code. Recent solicitations show county health departments, state health and human services agencies, and cooperative purchasing alliances sourcing pharmaceutical inventory for distribution to community health facilities, emergency response programs, and state employee health plans. The work ranges from direct product procurement with wholesaler distribution networks to exploratory market intelligence gathering around direct-to-manufacturer contracting models and pharmacy benefit program redesign. Issuing bodies include county procurement offices (Seminole County, Florida), state health and human services commissions (Texas HHS), and multistate cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance, or MMCAP).

Activity concentrates in Florida, Texas, and Minnesota based on recent postings. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023 response deadline and quarterly delivery to the Seminole County Community Health Building in Sanford. The Texas Health and Human Services Commission issued RFI HHS0017013 on April 3, 2026, to gather vendor capabilities for a Therapeutic Pharmacy Initiative focused on direct-to-manufacturer prescription fulfillment and cost management outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration, administering MMCAP, posted an RFP on January 20, 2026, with a March 26, 2026 response deadline to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) with contract awards effective July 1, 2026. Vendors responding to pharmaceutical procurement under this code typically must certify compliance with current Good Manufacturing Practices, the Drug Supply Chain Security Act, and FDA requirements; maintain specified insurance coverages; and demonstrate pricing flexibility across multiple net-price and WAC-based models.